《亚洲药物制剂科学(英文版)》双月刊征稿

Asian Journal of Pharmaceutical Sciences
亚洲药物制剂科学(英文版)

CASCIWJCI 卓越期刊
基本信息
主办单位：沈阳药科大学

出版周期：双月

ISSN：1818-0876

CN：21-1608/R

出版地：辽宁省沈阳市

语种：英文;

开本：大16开

创刊时间：2016

出版信息
专辑名称： 医药卫生科技

专题名称： 药学

出版文献量：371篇

评价信息
(2022)复合影响因子：1.438

(2022)综合影响因子：0.95

该刊被以下数据库收录：
CA 化学文摘(美)(2022)

SCI 科学引文索引(美)(2022)

WJCI 科技期刊世界影响力指数报告（2021）来源期刊

期刊荣誉：

中国科技期刊卓越行动计划入选项目;

《亚洲药物制剂科学(英文版)》论文发表目录：
Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A reviewKa Hong Wong;Donglin Yang;Shanshan Chen;Chengwei He;Meiwan Chen;475-490
mRNA vaccines:Past,present,futureMia Karam;Georges Daoud;491-522
Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriersYingke Liu;Zhihe Zhao;Man Li;523-543
Research article
Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicityYuri Svirkin;Jaeweon Lee;Richard Marx;Seongkyu Yoon;Nelson Landrau;Md Abul Kaisar;Bin Qin;Jin H. Park;Khondoker Alam;Darby Kozak;Yan Wang;Xiaoming Xu;Jiwen Zheng;Benjamin Rivnay;544-556
Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapyShengmei Wang;Xuanjun Liu;Minghua Yang;Linqi Ouyang;Jinsong Ding;Shengfeng Wang;Wenhu Zhou;557-570
Nucleobase-crosslinked poly(2-oxazoline)nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapySi Dong;Sheng Ma;Hongyu Chen;Zhaohui Tang;Wantong Song;Mingxiao Deng;571-582
Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapyYang Sui;Ji Li;Jiqiang Qu;Ting Fang;Hongyan Zhang;Jian Zhang;Zheran Wang;Mingyu Xia;Yinghui Dai;Dongkai Wang;583-595
Design, preparation and pharmacodynamics of ICG-Fe(Ⅲ) based HCPT nanocrystals against cancerQiongzhe Ren;Xuefeng Tang;Yi Lu;Qing Li;Zhiqian Liao;Shinan Jiang;Haoli Zhang;Zhigang Xu;Lei Luo;596-609
Erratum
Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”Chenyu Wang;Linglin Feng;Xiangkun Yang;Fei Wang;Weiyue Lu;610-611